Last reviewed · How we verify

NCT05347121

Difficult Airway and Ultrasonographic Evaluation

Completed Last updated 26 April 2022
What this trial tests

trial testing difficult airway in Difficult Airway in 120 participants. Completed in 3 November 2021.

Timeline
3 September 2021
Primary endpoint
28 September 2021
3 November 2021

Quick facts

Lead sponsorKocaeli University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment120
Start date3 September 2021
Primary completion28 September 2021
Estimated completion3 November 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kocaeli University

Who can join

18 and older, any sex, with Difficult Airway. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, it was planned to evaluate the preoperative neck ultrasonography measurements as a predictor of difficult airway in adult patients who will undergo elective surgery under general anesthesia.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Evaluation of neck ultrasound measurements as a difficult airway predictor: A prospective observational study.
    Çinar Köse EÖ, Tekin M, Cesur S, Çam İ, et al · · 2024 · PMID 39029084 · DOI 10.1097/md.0000000000038591
  2. Evaluation of Neck Ultrasound Measurements as a Difficult Airway Predictor
    Köse EÖÇ, Tekin M, Cesur S, Çam İ, et al · · 2023 · DOI 10.21203/rs.3.rs-3088145/v1

Verify or expand the search:

Other trials of difficult airway

Trials testing the same drug.

Other recruiting trials for Difficult Airway

Currently open trials in the same condition.

Other Kocaeli University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05347121.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing